AqueSys, a life sciences firm focusing on developing treatments for glaucoma, has secured $43.6m in its series D round, according to a SEC filing.
Backers in the round include venture firms Accuitive Medical Ventures, Longitude Capital, Rho Ventures, and SV Life Sciences. Private equity firm the Carlyle Group also backed the round.
All the backers in the latest round also participated in a series C held in 2010 worth $35m. In total, AqueSys has received upwards of $78m in…
In 2020, Stellenbosch University launched Africa's first-ever university venture fund focused on spinouts — here's how it's reshaping the country.
Global University Venturing (GUV) is where tech transfer, academic and investment experts meet to explore the latest ideas and technologies driving innovation forward. We drive the discussions and share best practices that are critical to the success of spinouts, scaleouts and innovation programmes. Our aim is to help improve the processes of bringing innovations from academia to global markets and facilitate their integration into the broader business ecosystem.
